On Friday, Allogene Therapeutics Inc (NASDAQ: ALLO) was -18.54% drop from the session before settling in for the closing price of $1.51. A 52-week range for ALLO has been $0.86 – $3.78.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 6.26%. When this article was written, the company’s average yearly earnings per share was at 27.37%. With a float of $153.71 million, this company’s outstanding shares have now reached $220.13 million.
Allogene Therapeutics Inc (ALLO) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Allogene Therapeutics Inc stocks. The insider ownership of Allogene Therapeutics Inc is 31.06%, while institutional ownership is 60.65%. The most recent insider transaction that took place on Jun 10 ’25, was worth 52,377. In this transaction Director of this company sold 36,885 shares at a rate of $1.42, taking the stock ownership to the 107,431 shares. Before that another transaction happened on Jun 10 ’25, when Company’s Director proposed sale 36,885 for $1.42, making the entire transaction worth $52,391.
Allogene Therapeutics Inc (ALLO) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.27 earnings per share (EPS) during the time that was better than consensus figure (set at -0.33) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.60% during the next five years compared to 6.26% growth over the previous five years of trading.
Allogene Therapeutics Inc (NASDAQ: ALLO) Trading Performance Indicators
You can see what Allogene Therapeutics Inc (ALLO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.11, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.88 in one year’s time.
